PHEN's Boston Community Rally Focuses on Importance of Clinical Trials for Black Men

“Advocacy does its work on behalf of patients. The community is critically important,” said Ms. Cassandra Smith. “I’m very passionate about the role clinical research plays in disease care and management. It’s often overlooked, especially in communities of color. It’s a place where you can get cutting-edge care and access to cutting-edge science before it’s available. It ensures the medications that are about to be put on the market actually work in your body.”

Pictured above: Ms. Cassandra Smith, MBA, Director, Health Equity, Amgen

Watch Video

Prostate Cancer That Spreads to the Liver: Here's What High-Risk Men Should Know

One of the most difficult aspects of the prostate cancer journey is the potential for a late-stage diagnosis and spread of cancer throughout the body. There is new research among prostate cancer patients with metastasis in the liver.


Focus on High-Risk Men

Some men have a higher chance of developing advanced disease because of factors like African ancestry, family history, or genetic traits. Studies show that when these men have access to early screening and genetic testing, they can have better outcomes from more precise treatments.



  • Broad Clinical Research Participation: It’s important to include men of all backgrounds in clinical trials so that new treatments can help everyone.
  • Precision Medicine: Genomic tests can reveal which treatments will work best for each person.


Read More Here

The MEVPRO Clinical Trials:

What You Need to Know

The MEVPRO clinical trial program is an investigational prostate cancer treatment option for patients with metastatic prostate cancer. These clinical trials provide patients with the study medicine, Mevrometostat, which is taken as tablets twice per day with enzalutamide.


How does Mevrometostat work? The study medicine targets the EZH2 protein known for controlling cell growth. In some people, the EZH2 gene may become abnormal or make too much of the proteins, which can cause prostate cancer cells to grow and the cancer to progress. By blocking the abnormal EZH2 activity in cells, the study medicine may help prevent or delay hormone therapy resistance and cancer progression.


This could be an important development and make a difference in outcomes for men with prostate cancer that become resistant to hormone therapy. These clinical trials are meant to help patients diagnosed with metastatic castrate-resistant prostate cancer (mCRPC). mCRPC is an advanced form of prostate cancer that no longer responds to hormone therapy. Read More Here to See if You're Eligible to Participate

Highlighted Clinical Trials

MEVPRO-1

The primary objective of this clinical trial is to assess the efficacy of combining the study medicine (mevrometostat) with a standard therapy (enzalutamide) to treat metastatic castration-resistant prostate cancer (mCRPC), which will be compared to standard treatments alone (either enzalutamide or docetaxel).

View Patient Summary

MEVPRO-2

The primary objective of this clinical trial is to assess the efficacy of combining the study medicine (mevrometostat) with a standard therapy (enzalutamide) to treat metastatic castration–resistant prostate cancer (mCRPC) compared to placebo in combination with enzalutamide.

Visit Patient Summary

For more clinical trial information, please visit PHENTrials.com

Visit PHENTrials.com

Upcoming Events

Wednesday, May 14th @ 6:00 pm: Managing Survivorship Meeting


Every month, PHEN brings in leading doctors and survivors to discuss issues facing prostate cancer patients. You will also be shown how to use the many tools and resources PHEN offers to help empower you along your prostate cancer journey.


Register for Managing Survivorship Meeting

Wednesday, May 21st @ 6:00 pm: Clinical Trials Learning Session


Join Dr. Keith Crawford, PHEN Director of Clinical Trials and Patient Education and Dr. Neal Shore, Medical Director at Carolina Urologic Research Center, to learn about new clinical trials which could benefit you.


Register for Clinical Trials Learning Session

Facebook  X  Instagram